Lisata Therapeutics Statistics
Total Valuation
LSTA has a market cap or net worth of $29.49 million. The enterprise value is -$13.86 million.
| Market Cap | 29.49M |
| Enterprise Value | -13.86M |
Important Dates
The next estimated earnings date is Monday, August 12, 2024, after market close.
| Earnings Date | Aug 12, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
LSTA has 8.31 million shares outstanding. The number of shares has increased by 3.84% in one year.
| Shares Outstanding | 8.31M |
| Shares Change (YoY) | +3.84% |
| Shares Change (QoQ) | +1.87% |
| Owned by Insiders (%) | 18.78% |
| Owned by Institutions (%) | 8.91% |
| Float | 6.89M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 0.69 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 8.92, with zero debt.
| Current Ratio | 8.92 |
| Quick Ratio | n/a |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -39.70% and return on invested capital (ROIC) is -59.23%.
| Return on Equity (ROE) | -39.70% |
| Return on Assets (ROA) | -35.90% |
| Return on Capital (ROIC) | -59.23% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$802,160 |
| Employee Count | 25 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -3.13M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -3.40% in the last 52 weeks. The beta is 1.24, so LSTA's price volatility has been higher than the market average.
| Beta (5Y) | 1.24 |
| 52-Week Price Change | -3.40% |
| 50-Day Moving Average | 3.27 |
| 200-Day Moving Average | 2.84 |
| Relative Strength Index (RSI) | 54.39 |
| Average Volume (20 Days) | 17,738 |
Short Selling Information
The latest short interest is 14,491, so 0.17% of the outstanding shares have been sold short.
| Short Interest | 14,491 |
| Short Previous Month | 13,123 |
| Short % of Shares Out | 0.17% |
| Short % of Float | 0.21% |
| Short Ratio (days to cover) | 0.63 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -25.47M |
| Pretax Income | -23.18M |
| Net Income | -20.05M |
| EBITDA | -23.00M |
| EBIT | -23.18M |
| Earnings Per Share (EPS) | -$2.46 |
Balance Sheet
The company has $43.35 million in cash and no debt, giving a net cash position of $43.35 million or $5.22 per share.
| Cash & Cash Equivalents | 43.35M |
| Total Debt | n/a |
| Net Cash | 43.35M |
| Net Cash Per Share | $5.22 |
| Equity (Book Value) | 43.00M |
| Book Value Per Share | 5.18 |
| Working Capital | 42.23M |
Cash Flow
| Operating Cash Flow | -18.86M |
| Capital Expenditures | n/a |
| Free Cash Flow | -18.86M |
| FCF Per Share | -$2.27 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
LSTA does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -3.84% |
| Shareholder Yield | -3.84% |
| Earnings Yield | -68.00% |
| FCF Yield | -63.96% |
Analyst Forecast
The average price target for LSTA is $15.00, which is 322.54% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $15.00 |
| Price Target Difference | 322.54% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 1 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | -7.97% |
Stock Splits
The last stock split was on September 15, 2022. It was a reverse split with a ratio of 1:15.
| Last Split Date | Sep 15, 2022 |
| Split Type | Reverse |
| Split Ratio | 1:15 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |